Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Assets: 2010-2025

Historic Assets for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $65.7 million.

  • ProPhase Labs' Assets fell 28.44% to $65.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.7 million, marking a year-over-year decrease of 28.44%. This contributed to the annual value of $63.2 million for FY2024, which is 31.25% down from last year.
  • As of Q3 2025, ProPhase Labs' Assets stood at $65.7 million, which was up 56.28% from $42.0 million recorded in Q2 2025.
  • ProPhase Labs' Assets' 5-year high stood at $99.7 million during Q1 2022, with a 5-year trough of $42.0 million in Q2 2025.
  • Its 3-year average for Assets is $78.8 million, with a median of $91.1 million in 2023.
  • Per our database at Business Quant, ProPhase Labs' Assets spiked by 619.95% in 2021 and then plummeted by 55.12% in 2025.
  • Quarterly analysis of 5 years shows ProPhase Labs' Assets stood at $89.3 million in 2021, then declined by 1.84% to $87.6 million in 2022, then rose by 4.88% to $91.9 million in 2023, then plummeted by 31.25% to $63.2 million in 2024, then fell by 28.44% to $65.7 million in 2025.
  • Its Assets stands at $65.7 million for Q3 2025, versus $42.0 million for Q2 2025 and $50.1 million for Q1 2025.